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Objective: This study was undertaken to determine the results of subfascial endoscopic perforator vein surgery (SEPS)
combined with ablation of superficial venous reflux.
Methods: Clinical data were retrospectively analyzed for 74 consecutive limbs (65 patients) in which this combination
treatment was performed at a university medical center. Preoperatively, 58 lower extremities had an open venous ulcer
(CEAP clinical class 6 [C6]) and 16 had healed ulceration (C5). Preoperative and postoperative ulcer care remained
constant. Main outcomes measured included perioperative complications, ulcer healing, and ulcer recurrence. Clinical
severity and disability scores were tabulated before and after surgery. Mean patient follow-up was 44 months.
Results: Greater saphenous vein (GSV) stripping and varicose vein excision accompanied SEPS in 57 limbs (77%), and
SEPS was performed alone or with varicose vein excision in 17 limbs that had previously undergone GSV stripping.
Postoperative complications occurred in 12 limbs (16%), all with C6 disease (P .04). Ulcer healing occurred in 91% (53
of 58) of limbs with C6 disease at a mean of 2.9 months (range, 13 days-17 months). Multivariate analysis demonstrated
that ulcer healing was negatively affected by previous limb trauma (P  .011). Ulceration recurred in 4 limbs (6%) at 7,
20, 21, and 30 months, respectively. This was associated with a history of limb trauma (P  .027) and preoperative
ultrasound evidence of GSV reflux combined with deep venous obstruction (PR,O; P  .043). Clinical severity and
disability scores improved significantly after surgery (both, P < .0001).
Conclusions: Most venous ulcers treated with SEPS with ablation of superficial venous reflux heal rapidly and remain
healed during medium-term follow-up. Ulcer healing is adversely affected by a history of severe limb trauma, and ulcer
recurrence is similarly affected by a history of limb trauma in addition to superficial venous reflux combined with deep
venous obstructive disease. Overall, there was marked improvement of postoperative clinical severity and disability scores
compared with those obtained before surgery. (J Vasc Surg 2003;38:67-71.)
Optimal surgical treatment for advanced chronic ve-
nous insufficiency (CVI) remains controversial and has yet
to be determined in any large prospectively randomized
clinical trial.1 Nevertheless, subfascial endoscopic interrup-
tion of perforating veins (SEPS) combined with ablation of
axial superficial venous reflux has emerged as a potentially
useful therapeutic option in patients with severe forms of
CVI, particularly CEAP clinical class 5 and 6 disease.2-5
Single center and multicenter reports have established
safety and feasibility of this procedure, and encouraging
early and mid-term results.2-5 Furthermore, randomized
clinical trials have demonstrated that when SEPS is com-
pared with open perforator vein ligation, ulcer healing and
recurrence rates are similar but there is significantly less
morbidity with SEPS.6,7
Our early experience strongly suggested that SEPS
combined with ablation of greater saphenous vein (GSV)
reflux accelerated venous ulcer healing.2 Therefore we con-
tinued to use this treatment algorithm in patients with
severe forms of CVI.
In this updated report we present mid-term results of
SEPS combined with ablation of axial superficial venous
reflux.
METHODS
Review of a prospectively maintained vascular registry
identified 65 consecutive patients (74 lower extremities)
with CEAP clinical class 5 or 6 CVI who had undergone
SEPS between June 1995 and February 2002 at the outpa-
tient surgery center of Loma Linda University Medical
Center. SEPS was uniformly performed with a single-port,
open scope technique, with subfascial dissection guided
with preoperative duplex ultrasound (US) scanning of in-
competent perforating veins (IPVs).3 The superficial pos-
terior compartment was thoroughly explored in each case.
Fasciotomy of the deep posterior compartment was not
routinely performed in the first 23 patients; however, ex-
ploration of this deep compartment was routinely added to
the procedure in 1997. Perforating veins were clipped and
divided under video assistance. If present and demon-
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strated to have pathologic reflux at preoperative duplex US
scanning, the ipsilateral GSV was disconnected from the
saphenofemoral junction and stripped distally to the level of
the mid-leg. In addition, stab avulsion of varicose veins and
varicose clusters was performed along with GSV stripping
in patients with symptomatic varicosities. Ulcer debride-
ment and application of pressure dressings completed the
operation.
Patients were discharged to home on the day of sur-
gery, and were instructed to ambulate as desired. Dressings
were left intact for 48 hours, and preoperative ulcer care
was resumed after the first dressing change. Outpatient
follow-up visits commenced within 3 weeks of operative
intervention.
Data were collected in accordance with reporting stan-
dards established by the International Consensus Commit-
tee on Chronic Venous Disease.8 Main outcome measures
included perioperative complications, primary ulcer heal-
ing, and ulcer recurrence. Clinical severity and disability
scores were also tabulated before and after surgery (Tables
I and II). Follow-up data were derived from personal
contact with each patient in the vascular surgery clinic and
telephone survey to determine whether ulcer outcome had
not changed since the last clinic visit.
Clinical data were exported into a statistical software
program (SPSS for Windows, version 10; SPSS, Chicago,
Ill) and evaluated with the Student t test, X2 analysis, and
univariate or multivariate logistic regression analysis. Rates
of ulcer healing and recurrence were also evaluated with
standard life tables, the Kaplan-Meier method, and Cox
regression analysis. P  .05 was considered statistically
significant.
RESULTS
The 65 patients included 42 men and 23 women, with
mean age 55 years (range, 33-86 years). Mean preoperative
clinical severity score was 8.65, and mean disability score
was 1.92. Fifteen patients (20%) had a history of significant
ipsilateral limb trauma associated with crush injury or frac-
ture, and 5 of these patients (7%) had a documented history
of deep venous thrombosis (DVT). Five additional patients
(7%) had a history of spontaneous DVT in the treated limb
without a history of trauma. Four patients (5%) were receiv-
ing long-term estrogen or progesterone replacement ther-
apy, 1 patient (1.4%) had active cancer, and 2 patients
(2.7%) were morbidly obese (175% of ideal body weight).
Seventeen treated limbs (23%) had previously undergone
ipsilateral GSV stripping, which was confirmed at preoper-
ative duplex US scanning.
The clinical problem was open venous ulceration
(CEAP classification C6) in 58 limbs (78%). Sixteen limbs
(22%) had healed venous ulceration (C5). The etiologic
classification of CVI was primary (EP) in 65 limbs (88%)
and secondary (ES) in 9 limbs (12%). Twelve limbs (16%)
had more than one venous ulcer; in 47 limbs (64%) the
largest ulcer was larger than 2 cm in maximum diameter.
The ulcer had been present for more than 3 months in most
(89%) treated limbs. Before SEPS, 37% of limbs had been
treated with repeated Unna boot application; the remain-
der had been treated with a combination of compression,
elastic stockings, and moist dressings.
All 74 limbs demonstrated significant venous reflux
(0.5 seconds) in one or more venous segments, as deter-
mined with established duplex US scanning criteria.9 Most
limbs had perforator vein reflux in conjunction with super-
ficial venous reflux (31 limbs, 42%) or both superficial and
deep venous reflux (24 limbs, 32%). Nine limbs (12%) had
perforator and superficial venous reflux combined with
deep venous obstruction. Five limbs (7%) had perforator
vein reflux only. Reflux was limited to the superficial venous
system in 3 limbs (4%), and 2 limbs (3%) had superficial
combined with deep venous reflux. A mean of two (range,
1-5) medial calf perforating veins with reflux were identi-
fied at preoperative US scanning in 69 limbs (93%). Reflux
in imaged perforating veins was not present in five limbs
with C6 disease. Detailed information regarding CEAP
classification, procedure, outcome, and ulcer recurrence for
each limb treated is provided in Table III (online only).
The SEPS procedure was uniformly performed in all
cases as described previously.2,3 Fifty-seven limbs (77%)
underwent SEPS with concomitant stripping out of the
ipsilateral GSV and stab avulsion of painful varicose veins.
Of the 17 limbs that had undergone previous GSV strip-
ping, 8 limbs (11%) had SEPS with excision of varicose
veins and 9 limbs (12%) had SEPS alone. A mean of 3
(range, 1-7) perforating veins were ligated and divided at
surgery. All open ulcers (58 limbs) were debrided with a
curette and dressed with Xeroform gauze. Perioperative
Table I. Clinical severity of symptoms or signs
Symptom or sign Clinical score
Pain 0, none; 1, moderate, no analgesics
needed; 2, severe, necessitating
analgesics
Edema 0, none; 1, mild or moderate; 2, severe
Venous claudication 0, none; 1, mild or moderate; 2, severe
Pigmentation 0, none; 1, localized; 2, extensive
Lipodermatosclerosis 0, none; 1, localized; 2, extensive
Ulcer
Size (largest ulcer) 0, none; 1,  2,  2 cm
Duration 0, none; 1,  3 months; 2,  3 mo
Recurrence 0, none; 1, once; 2, more than once
Number 0, none; 1, single; 2, multiple
Reprinted with permission from Kistner RL, Eklof B, Masuda EM. Mayo
Clin Proc 1996;71:338-45.
Table II. Disability score
Score Extent of disability
0 Asymptomatic
1 Symptomatic; can function without support device
2 Can work 8-hour day only with support device
3 Unable to work even with support device
Reprinted with permission from Kistner RL, Eklof B, Masuda EM. Mayo
Clin Proc 1996;71:338-45.
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complications occurred in 12 limbs (16%) and included
wound infection (7 limbs), subfascial hematoma (3 limbs),
abscess (1 limb), and superficial thrombophlebitis (1 limb).
All complications occurred in limbs with C6 disease (P 
.04).
Overall mean follow-up was 44 months (range, 6-77
months), and no patient was lost to follow-up. Ulcer heal-
ing after SEPS occurred in 91% (53 of 58) of limbs with C6
disease by a mean of 2.9 months (range, 13 days-17
months; Fig 1). Five venous ulcers (9%) never healed,
despite surgical intervention. Univariate analysis demon-
strated that gender, hormone use, active cancer, and obe-
sity did not affect ulcer healing. In addition, healing was not
influenced by ulcer size, number of months the ulcer had
been present before surgery, history of GSV stripping, or
incidence of perioperative complications. A trend (not sta-
tistically significant) toward nonhealing was noted in limbs
with GSV reflux combined with deep venous obstructive
disease (PR,O; P  .054) and secondary disease (ES; P 
.078). Ulcer healing was negatively affected by a history of
limb trauma (P  .007, univariate analysis), and this vari-
able remained statistically significant at multivariate logistic
regression analysis (P  .011).
Recurrent venous ulceration occurred in 4 limbs (6%)
at a mean of 19 months (range, 7-30 months) after SEPS.
Freedom from ulcer recurrence at 4 years was 92% with life
table analysis (Fig 2). Univariate analysis demonstrated that
ulcer recurrence was associated with previous limb trauma
(P .011), limbs with PR,O (P .024), ulcer greater than
2 cm in largest diameter (P .042), and secondary disease
(P .048). However, multivariate logistic regression anal-
ysis demonstrated that only a history of limb trauma (P 
.027) and limbs with PR,O (P .043) remained statistically
significant.
Postoperative duplex US scanning was performed ap-
proximately 8 weeks after surgery in patients with C6 dis-
ease, but was not routinely performed in patients with C5
disease. Duplex US scanning was not regularly performed
later during clinical follow-up. One residual perforating
vein was confirmed to be functional at US scanning, and
was successfully ligated with the patient under local anes-
thesia. Clinical and disability scores, which were tabulated
before surgery and at latest follow-up, improved signifi-
cantly after SEPS. Mean clinical score improved from 8.65
to 2.59 (P  .0001; 95% confidence interval [CI], 5.46-
6.65), and mean disability score improved from 1.92 to
1.34 (P  .0001; 95% CI, 0.39-0.77).
DISCUSSION
The pathophysiology of CVI suggests that venous hy-
pertension is linked to severe skin changes and ulceration.
Furthermore, these changes can be favorably modified with
ablation of superficial venous reflux.10,11 Our working
hypothesis is that if this is done in combination with inter-
ruption of calf perforating veins, the water-hammer effect
of downward and outward venous flow through these veins
will be halted, leukocyte trapping and activation decreased,
and skin changes reversed.2,12 Our early favorable observa-
tions of rapid ulcer healing, improvement in lipodermato-
sclerosis, and fading of hyperpigmentation appeared di-
rectly related to correction of perforating and superficial
venous reflux by aggressive surgical intervention.2 Success-
ful wound healing and low ulcer recurrence, as demon-
strated in this report with medium-term follow-up, contin-
ues to support this hypothesis.
IPVs have a role in the development of chronic venous
ulceration. Numerous investigators have reported the clin-
ical benefits of interrupting medial calf perforator veins,
including the seminal work of Linton,13 Cockett,14 and
Stuart et al,15 and the North American Subfascial Endo-
scopic Perforator Surgery Registry.4,5 Nevertheless, we rec-
ognize that the optimal approach for treating the limb with
C5 or C6 disease with reflux confined to perforating veins
and the superficial venous system remains unsettled at this
Fig 1. Life table depicts healing time for limbs with C6 disease.
Standard error less than 10% for entire plot. Limbs at risk are noted
at each time interval.
Fig 2. Life table depicts freedom from ulcer recurrence for limbs
with C5 disease, and limbs with C6 disease with ulcer healing.
Standard error less than 10% for entire plot. Limbs at risk are noted
at each time interval.
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time. Uncontrolled data support the finding that ablation
of superficial venous reflux, together with multiple phlebec-
tomy, promotes wound healing and decreases ulcer recur-
rence.11,16,17 Bello et al11 demonstrated that this treatment
leads to ulcer healing in a mean of 18 weeks in most limbs
with C6EPPR disease in the absence of deep venous reflux.
These authors suggested that in this selected population
ulcer healing could be accomplished without perforator
vein ligation, postoperative compression bandaging, or skin
grafting.
In that report,10 patients were recruited for surgery if
they had venous ulceration and isolated superficial venous
reflux. Of interest, IPVs were detected in only 6% of limbs
at duplex US scanning. In our experience, C6–diseased
limbs often have one or more perforating veins in close
proximity to the active ulcer, even when pathologic out-
ward perforator flow is not demonstrated on duplex US
scans.9 Preoperative noninvasive testing in our current
experience identified IPV in all but five cases. Notwith-
standing the ability to image refluxing perforating veins, we
have continued to perform SEPS, more on the basis of
clinical presentation (ie, C5 and C6 disease) than on the
relationship of possible IPVs to type of venous reflux.
Furthermore, ulcer healing was accelerated in this experi-
ence when SEPS was combined with ablation of superficial
venous reflux, compared with the reports of Bello et al11
(2.5 vs 4.5 months), and others.2,16,17
Ablation of superficial venous reflux results in hemody-
namic improvement of synchronous “secondary” deep ve-
nous reflux.18,19 However, whether this maneuver alone
will also correct IPVs and accelerate wound healing has not
been determined with certainty. Stuart et al15 reported that
eradication of superficial venous reflux alone corrected IPV
in most cases in which reflux was confined only to the
superficial venous system. However, they commented that
there were no preoperative markers that could be used to
identify the 20% of patients with severe CVI who may also
benefit from SEPS. IPVs were still observed in 72% of
patients with residual deep venous reflux or in whom
surgery had failed to resolve superficial venous reflux. They
suggested that SEPS was the only reliable way to correct
pathologic outward flow in the perforating veins when
there was persistent superficial reflux or coexistent deep
venous reflux.15
In our current SEPS experience, 17 limbs (23%) had
severe CVI despite previous GSV stripping. Twelve of these
limbs had active venous ulceration (C6), and 5 demon-
strated healed ulceration (C5). Of interest, in all but one of
those cases the cause was primarily deep venous reflux
(EPPR), and in the other case was ESPR,O. Preoperative
perforating vein reflux was noted in 15 of 17 limbs (88%),
with a mean of 2 (range, 0-4) refluxing perforator veins per
limb. SEPS resulted in ulcer healing in the 12 limbs with
open ulcers, and no recurrent ulcers were noted in this
subset of our patient cohort. In these cases previous abla-
tion of superficial venous reflux alone did not ameliorate
deep venous or perforating vein reflux, nor did it signifi-
cantly affect ulcer healing rate.
Our observed overall ulcer healing rate is similar to that
of other reports,4,5,7,20,21 and was significantly influenced
by a previous history of significant limb trauma. Ulcer
recurrence was also affected by limb trauma and deep
venous obstructive pathophysiology in conjunction with
superficial venous reflux. The overall ulcer recurrence rate
(6%) is lower than that previously reported in the litera-
ture,4,5,7,20,21 and survival free ulcer recurrence at 4 years
was 92% with life table analysis. This may reflect that SEPS
was performed uniformly in each limb and that one surgeon
performed 80% of the procedures.
This nonrandomized case series suggests that SEPS
combined with saphenous vein ablation is most advanta-
geous in the setting of IPVs and superficial venous reflux. It
also appears to be beneficial when IPVs are associated with
deep venous reflux alone or when there is combined super-
ficial and deep venous reflux. However, a prospective ran-
domized trial will be necessary to determine whether the
clinical and hemodynamic consequences of SEPS merit the
potential added morbidity. In the present experience there
was no increase in complications in the SEPS without GSV
stripping group, and outcome (healing and recurrence) was
similar to that in limbs in which SEPS was combined with
GSV stripping or varicose vein excision. Even so, preoper-
ative counseling should mention that there is a predictable
but manageable set of perioperative complications that are
primarily related to the leg incision used for SEPS, which is
frequently made through compromised skin and soft tissue.
Advanced CVI remains a distressing and disabling con-
dition. However, in limbs selected for SEPS combined with
ablation of superficial venous reflux, with appropriate clin-
ical criteria and accurate preoperative hemodynamic data,
there will rapid ulcer healing and low ulcer recurrence
during medium-term follow-up in the overwhelming ma-
jority of patients. Expectations with surgical therapy should
be somewhat tempered in limbs with PR,O disease and
those with a history of significant trauma, because there
may be delayed wound healing or ulcer recurrence. Never-
theless our observations offer more than just a glimmer of
hope for limbs with C5 or C6 disease with severe skin
changes or in which conservative wound treatment has
failed.
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